- Görüntülenme 4
- İndirme 0
-
Google Akademik
-
DOI
| Yazarlar | Yildirim,Nazim Unal,Selma Karahan,Feryal |
| Kurum Dışı Yazarlar | Yalcinkaya,Ahmet Oztas,Yesim |
| Tek Biçim Adres (URI) | https://hdl.handle.net/20.500.14114/9785 |
| Yayın Türü | Makale |
| Yayın Yılı | 2021 |
| DOI Adresi | DOI: 10.1007/s00277-021-04667-w |
| Yayıncı | Springer Nature |
| Dergi Adı | Annals of Hematology |
| Konu Başlıkları | Sickle cell disease · Acute chest syndrome · Vaso-occlusive crisis · Nitric oxide · Acid sphingomyelinase · Hemopexin |
| İndekslenen Platformlar | PubMed |
The aims of this study were to determine the possible relationships between the levels of hemin, hemopexin, acid sphingomyelinase, nitrite/nitrate (NOx), and other parameters in patients with SCD and to assess whether they were associated with vaso-occlusive crises (VOCs) or acute chest syndrome (ACS). Patients with SCD (homozygous or sickle beta-thalassemia) who were confirmed to have VOC or ACS were included. Blood samples were obtained at admission, on the third day of hospitalization, and at steady state. Demographic characteristics, pain (visual analog scale), complication history, complete blood count, lactate dehydrogenase, and C-reactive protein levels were recorded. Hemin, hemopexin, acid sphingomyelinase, and NOx were measured via ELISA. A total of 31 patients (22 VOC, 9 ACS) were included. Mean age was 16.4 ± 4.7 years. Admission white blood cell count and C-reactive protein levels were significantly higher in the ACS group. Patients with ACS also demonstrated a significant decreasing trend of LDH and an increasing trend of NOx values from admission to steady state. Notably, hemopexin levels were significantly lower on the third day of hospitalization compared to steady-state levels. Despite limited patient count in the ACS group, these patients appear to have strikingly greater inflammatory activation at admission, and the progression of ACS may be associated with LDH and NOx levels. Lower hemopexin levels during hospitalization versus steady state appear to support a role for the administration of hemopexin therapy during crises.
- Fakülteler
- Tıp Fakültesi
- Dahili Tıp Bilimleri Bölümü
- Çocuk Sağlığı ve Hastalıkları Anabilim Dalı
|
Eser Adı dc.title |
Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome |
|---|---|
|
Yazarlar dc.contributor.author |
Yildirim,Nazim |
|
Yazarlar dc.contributor.author |
Unal,Selma |
|
Yazarlar dc.contributor.author |
Karahan,Feryal |
|
Kurum Dışı Yazarlar dc.contributor.other |
Yalcinkaya,Ahmet |
|
Kurum Dışı Yazarlar dc.contributor.other |
Oztas,Yesim |
|
Yayıncı dc.publisher |
Springer Nature |
|
Yayın Türü dc.type |
Makale |
|
Özet dc.description.abstract |
The aims of this study were to determine the possible relationships between the levels of hemin, hemopexin, acid sphingomyelinase, nitrite/nitrate (NOx), and other parameters in patients with SCD and to assess whether they were associated with vaso-occlusive crises (VOCs) or acute chest syndrome (ACS). Patients with SCD (homozygous or sickle beta-thalassemia) who were confirmed to have VOC or ACS were included. Blood samples were obtained at admission, on the third day of hospitalization, and at steady state. Demographic characteristics, pain (visual analog scale), complication history, complete blood count, lactate dehydrogenase, and C-reactive protein levels were recorded. Hemin, hemopexin, acid sphingomyelinase, and NOx were measured via ELISA. A total of 31 patients (22 VOC, 9 ACS) were included. Mean age was 16.4 ± 4.7 years. Admission white blood cell count and C-reactive protein levels were significantly higher in the ACS group. Patients with ACS also demonstrated a significant decreasing trend of LDH and an increasing trend of NOx values from admission to steady state. Notably, hemopexin levels were significantly lower on the third day of hospitalization compared to steady-state levels. Despite limited patient count in the ACS group, these patients appear to have strikingly greater inflammatory activation at admission, and the progression of ACS may be associated with LDH and NOx levels. Lower hemopexin levels during hospitalization versus steady state appear to support a role for the administration of hemopexin therapy during crises. |
|
Kayıt Giriş Tarihi dc.date.accessioned |
2026-01-31 |
|
Yayın Yılı dc.date.issued |
2021 |
|
Açık Erișim Tarihi dc.date.available |
2026-02-02 |
|
Dil dc.language.iso |
eng |
|
Konu Başlıkları dc.subject |
Sickle cell disease · Acute chest syndrome · Vaso-occlusive crisis · Nitric oxide · Acid sphingomyelinase · Hemopexin |
|
Atıf İçin Künye dc.identifier.citation |
Ann Hematol. 2022 Jan;101(1):35-41. doi: 10.1007/s00277-021-04667-w. Epub 2021 Sep 25. Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome Nazim Yildirim 1, Selma Unal 1, Ahmet Yalcinkaya 2, Feryal Karahan 1, Yesim Oztas 3 Affiliations Expand PMID: 34564750 DOI: 10.1007/s00277-021-04667-w |
|
ISSN dc.identifier.issn |
1432-0584 |
|
İlk Sayfa dc.identifier.startpage |
35 |
|
Son Sayfa dc.identifier.endpage |
41 |
|
Dergi Adı dc.relation.journal |
Annals of Hematology |
|
Dergi Sayısı dc.identifier.issue |
1 |
|
Dergi Cilt dc.identifier.volume |
101 |
|
Tek Biçim Adres (URI) dc.identifier.uri |
https://hdl.handle.net/20.500.14114/9785 |
|
DOI Numarası dc.identifier.doi |
DOI: 10.1007/s00277-021-04667-w |
|
İndekslenen Platformlar dc.source.database |
PubMed |